Ribonucleotide Reductases
"Ribonucleotide Reductases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
No definition found.
| Descriptor ID |
D012264
|
| MeSH Number(s) |
D08.811.682.810
|
| Concept/Terms |
Ribonucleotide Reductases- Ribonucleotide Reductases
- Reductases, Ribonucleotide
- Ribonucleotide Reductase
- Reductase, Ribonucleotide
|
Below are MeSH descriptors whose meaning is more general than "Ribonucleotide Reductases".
Below are MeSH descriptors whose meaning is more specific than "Ribonucleotide Reductases".
This graph shows the total number of publications written about "Ribonucleotide Reductases" by people in this website by year, and whether "Ribonucleotide Reductases" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 1 | 0 | 1 |
| 2001 | 1 | 0 | 1 |
| 2003 | 0 | 1 | 1 |
| 2009 | 1 | 1 | 2 |
| 2013 | 1 | 0 | 1 |
| 2018 | 0 | 1 | 1 |
| 2021 | 0 | 1 | 1 |
| 2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Ribonucleotide Reductases" by people in Profiles.
-
RRM1 variants cause a mitochondrial DNA maintenance disorder via impaired de novo nucleotide synthesis. J Clin Invest. 2022 07 01; 132(13).
-
Hydroxyurea Induces a Stress Response That Alters DNA Replication and Nucleotide Metabolism in Bacillus subtilis. J Bacteriol. 2021 07 08; 203(15):e0017121.
-
Previously uncharacterized amino acid residues in histone H3 and H4 mutants with roles in DNA damage repair response and cellular aging. FEBS J. 2019 03; 286(6):1154-1173.
-
Murine gammaherpesvirus 68 encodes a second PML-modifying protein. J Virol. 2014 Mar; 88(6):3591-7.
-
Mitochondrial neurogastrointestinal encephalopathy due to mutations in RRM2B. Arch Neurol. 2009 Aug; 66(8):1028-32.
-
Enzastaurin shows preclinical antitumor activity against human transitional cell carcinoma and enhances the activity of gemcitabine. Mol Cancer Ther. 2009 Jul; 8(7):1772-8.
-
Phase I and pharmacodynamic study of Triapine, a novel ribonucleotide reductase inhibitor, in patients with advanced leukemia. Leuk Res. 2003 Dec; 27(12):1077-83.
-
Combining inference from evolution and geometric probability in protein structure evaluation. J Mol Biol. 2003 Aug 01; 331(1):263-79.
-
Gemcitabine in breast cancer: future directions. Clin Breast Cancer. 2002 May; 3 Suppl 1:45-8.
-
Overview: gemcitabine as single-agent therapy for advanced breast cancer. Clin Breast Cancer. 2002 May; 3 Suppl 1:8-11.